Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat

American Journal of Hypertension

Volumn 23, Issue 12, 2010, Pages 1273-1278

  Behbahani, John ^a,b   Thandapilly, Sijo J ^b   Louis, Xavier L ^b   Huang, Yingsu ^b   Shao, Zongjun ^b   Kopilas, Melanie A ^b   Wojciechowski, Peter ^b   Netticadan, Thomas ^b   Anderson, Hope D ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

blood pressure; elastic modulus; hypertension; resveratrol; SHR; small arteries; vascular resistance

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GEOMETRY; INTESTINE PRESSURE; MALE; MECHANICS; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT; AGING; ANIMAL; BLOOD PRESSURE; COMPLIANCE (PHYSICAL); DRUG EFFECT; HYPERTENSION; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR RESISTANCE;

AGING; ANIMALS; BLOOD PRESSURE; COMPLIANCE; HYPERTENSION; MALE; MESENTERIC ARTERIES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STILBENES; VASCULAR RESISTANCE;

EID: 79952276355     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2010.161     Document Type: Article

References (40)

1. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36:312-318.
2. Hajdu MA, Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol 1994; 266:H1027-H1033.
3. Baumbach GL, Dobrin PB, Hart MN, Heistad DD. Mechanics of cerebral arterioles in hypertensive rats. Circ Res 1988; 62:56-64. (Pubitemid 18032074)
4. Laurant P, Touyz RM, Schiffrin EL. Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 1997; 34:117-125. (Pubitemid 27193331)
5. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999; 100:2267-2275.
6. Mulvany MJ, Hansen OK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854-864.
7. Mulvany MJ, Korsgaard N. Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats. J Hypertens 1983; 1:235-244. (Pubitemid 14161947)
8. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (review). Int J Mol Med 2001; 8:3-17.
9. Yadav M, Jain S, Bhardwaj A, Nagpal R, Puniya M, Tomar R, Singh V, Parkash O, Prasad GB, Marotta F, Yadav H. Biological and medicinal properties of grapes and their bioactive constituents: an update. J Med Food 2009; 12:473-484.
10. Aubin MC, Lajoie C, Clément R, Gosselin H, Calderone A, Perrault LP. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Ther 2008; 325:961-968. (Pubitemid 351724317)
11. Liu Z, Song Y, Zhang X, Liu Z, Zhang W, Mao W, Wang W, Cui W, Zhang X, Jia X, Li N, Han C, Liu C. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin Exp Pharmacol Physiol 2005; 32:1049-1054. (Pubitemid 43906814)
12. Miatello R, Vázquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 2005; 18:864-870. (Pubitemid 40745275)
13. Rush JW, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood) 2007; 232:814-822. (Pubitemid 46827824)
14. Li JS, Sharifi AM, Schiffrin EL. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. J Cardiovasc Pharmacol 1997; 30: 75-83. (Pubitemid 27527377)
15. Sharifi AM, Li JS, Endemann D, Schiffrin EL. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 1998; 16:457-466. (Pubitemid 28195855)
16. Juric D, Wojciechowski P, Das DK, Netticadan T. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am J Physiol Heart Circ Physiol 2007; 292:H2138-H2143. (Pubitemid 47084592)
17. Short D. Morphology of the intestinal arterioles in chronic human hypertension. Br Heart J 1966; 28:184-192.
18. Falloon BJ, Bund SJ, Tulip JR, Heagerty AM. In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension 1993; 22:486-495. (Pubitemid 23292154)
19. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13:968-972. (Pubitemid 19157999)
20. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993; 21:391-397. (Pubitemid 23095149)
21. Hu F, Morrissey P, Yao J, Xu Z. Development of AT(1) and AT(2) receptors in the ovine fetal brain. Brain Res Dev Brain Res 2004; 150:51-61. (Pubitemid 39090083)
22. Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, Walter U, Skatchkov M, Meinertz T, Münzel T. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 2000; 87:999-1005.
23. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999; 33:569-574. (Pubitemid 29065722)
24. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension 1996; 28:505-506. (Pubitemid 26298571)
25. Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 2006; 24:983-991. (Pubitemid 43772300)
26. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91. (Pubitemid 24022048)
27. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a betablocker. Am J Hypertens 1995; 8:229-236.
28. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
29. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997; 15:197-204. (Pubitemid 27116503)
30. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101:1653-1659. (Pubitemid 30196624)
31. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994; 23:659-666. (Pubitemid 24129363)
32. Li JS, Schiffrin EL. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996; 28:68-74. (Pubitemid 26190457)
33. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Mulvany MJ, Agabiti Rosei E. Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 1998; 32:305-310. (Pubitemid 28376489)
34. Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2008; 28:1263-1269.
35. El Mabrouk M, Touyz RM, Schiffrin EL. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol 2001; 281:H30-H39.
36. Lee B, Lee EJ, Kim DI, Park SK, Kim WJ, Moon SK. Inhibition of proliferation and migration by piceatannol in vascular smooth muscle cells. Toxicol In Vitro 2009; 23:1284-1291.
37. El-Mowafy AM, Alkhalaf M, Nassar NN. Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes. Int J Cardiol 2009; 136:263-269.
38. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38:581-587.
39. Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U, Li H. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 2009; 60(Suppl 4): 111-116.
40. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2001; 28:55-59. (Pubitemid 32039558)